ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #13,700Hybrid

Molecular Syndromology

Abbreviation (ISO):MOL SYNDROMOL
•
Identifier (ISSN):1661-8769(Print)/1661-8777(Online)
•
Publisher:Karger
Clarivate IF (2026)
0.8↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Molecular Syndromology

WoS Q4
01231.220201.6320211.4920221.120230.920240.920250.82026
Annual Impact Factor Metric
Current (2026):0.8
Scopus SJR & RankScopus Q3
0.42
#13,700

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
47

47 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
65articles/year
3.5% Gold OA•81.82% Original Research

Aims & Scope

'Molecular Syndromology' publishes high-quality research articles, short reports and reviews on common and rare genetic syndromes, aiming to increase clinical understanding through molecular insights. Topics of particular interest are the molecular basis of genetic syndromes, genotype-phenotype correlation, natural history, strategies in disease management and novel therapeutic approaches based on molecular findings. Research on model systems is also welcome, especially when it is obviously relevant to human genetics. With high-quality reviews on current topics the journal aims to facilitate translation of research findings to a clinical setting while also stimulating further research on clinically relevant questions. The journal targets not only medical geneticists and basic biomedical researchers, but also clinicians dealing with genetic syndromes. With four Associate Editors from three continents and a broad international Editorial Board the journal welcomes submissions covering the latest research from around the world.

Topics Covered (Recognized by AI)
Medicine92.6%Biology90.5%Genetics86.7%Chemistry80.9%Biochemistry80.6%Gene78.3%Phenotype52.1%Internal medicine47.5%Psychology44.7%Psychiatry40.8%Mutation40.7%Pediatrics34.2%Pathology30%Surgery21.6%Anatomy20.7%Endocrinology20.6%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

GENETICS & HEREDITY

Q4
Rank185/192
IndexSCIE
JCISCIE2026

GENETICS & HEREDITY

Q4
Rank184/192
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF0.8
Articles / Year58
Total Citations1
2025
IF0.9
Articles / Year91
Total Citations20
2024
IF0.9
Articles / Year104
Total Citations122
2023
IF1.1
Articles / Year81
Total Citations262
2022
IF1.494
Articles / Year79
Total Citations301

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #13,700Scopus Q3SCImago Profile
Scopus Coverage:2010-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.42

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.06

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,812 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations249
3-Year Documents210
Citable Documents204

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate53.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Genetics (clinical)Q3
GeneticsQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区GENETICS & HEREDITY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Molecular Syndromology (abbr: MOL SYNDROMOL, ISSN: 1661-8769) is a peer-reviewed international scholarly journal in the field of Biochemistry, published by Karger in Switzerland. The periodical holds a Journal Impact Factor (JIF) of 0.80, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.420 (Q3), an H-index of 47.

The journal enforces rigorous peer evaluation with an annual output of approximately 65 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,812 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Karger
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ALLSCHWILERSTRASSE 10, BASEL, SWITZERLAND, CH-4009

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 2290eff6-29bb-406b-b82b-4f569b853906
Database Updated: 2026-10-01